Browse medicines, page 30 of 40

Use listed on the medicine record

Ergomar ® is indicated as therapy to abort or prevent vascular headache, e.g., migraine, migraine variants or so-called "histaminic cephalalgia".

Use listed on the medicine record

INDICATIONS & USAGE Estazolam is indicated for the short-term management of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings. Both outpatient studies and a sleep laboratory study have shown that estazolam administered at bedtime improved sleep induction and sleep maintenance (see CLINICAL PHARMACOLOGY ). Because insomnia is often transient and intermittent, the prolonged administration of estazolam is generally neither necessary nor recommended.

Use listed on the medicine record

Use by females of reproductive potential to prevent pregnancy

Use listed on the medicine record

Positron emission tomography (PET) of the brain to estimate amyloid beta neuritic plaque density

Use listed on the medicine record

Positron emission tomography (PET) of the brain to estimate amyloid beta neuritic plaque density

Use listed on the medicine record

Insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings [see Clinical Studies

Use listed on the medicine record

Generalized tonic-clonic status epilepticus and prevention and treatment of seizures occurring during neurosurgery

Use listed on the medicine record

Intravenous use in magnetic resonance imaging (MRI) of the central nervous system

Use listed on the medicine record

AMBELVIST is indicated in adult and pediatric patients, including term neonates, for use with magnetic resonance imaging (MRI) to detect and visualize lesions with abnormal vascularity in: the central nervous system (brain, spine, and associated tissues) the body (head and neck, thorax, abdomen, pelvis, and musculoskeletal system) AMBELVIST is a gadolinium-based contrast agent indicated in adult and pediatric patients, including term neonates, for use with magnetic resonance imaging (MRI) to detect and visualize lesions with abnormal vascularity in: the central nervous system (brain, spine,…

Use listed on the medicine record

The inhibition of premature LH surges

Use listed on the medicine record

Use with magnetic resonance imaging (MRI) for evaluation of lung ventilation

Use listed on the medicine record

The symptomatic relief of cough

Use listed on the medicine record

The gradual bleaching of hyperpigmented skin conditions age and liver spots, freckles, and other unwanted areas of melanin hyperpigmentation

Use listed on the medicine record

Pernicious anemia, both uncomplicated and accompanied by nervous system involvement. Dietary deficiency of Vitamin B 12 , occurring in strict vegetarians and in their breast-fed infants. (Isolated vitamin B 12 deficiency is very rare). Malabsorption of vitamin B 12 , resulting from structural or functional damage to the stomach, where intrinsic factor is secreted or to the ileum, where intrinsic factor facilitates vitamin B 12 absorption. These conditions include tropical sprue, and nontropical sprue (idiopathic steatorrhea, gluten-induced enteropathy).

Use listed on the medicine record

Moderate-to-severe plaque psoriasis

Use listed on the medicine record

FANAPT ® is indicated for: Treatment of schizophrenia in adults [see Clinical Studies (14.1) ]. Acute treatment of manic or mixed episodes associated with bipolar I disorder in adults [see Clinical Studies (14.2) ] . FANAPT is an atypical antipsychotic indicated for: Treatment of schizophrenia in adults. ( 1 , 14.1 ) Acute treatment of manic or mixed episodes associated with bipolar I disorder in adults. ( 1 , 14.2 )

Use listed on the medicine record

Imatinib mesylate is a kinase inhibitor indicated for the treatment of: Newly diagnosed adult and pediatric patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+CML) in chronic phase (1.1) Patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in blast crisis (BC), accelerated phase (AP), or in chronic phase (CP) after failure of interferon-alpha therapy (1.2) Adult patients with relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) (1.3) Pediatric patients with newly diagnosed Philadelphia chromosome…

Use listed on the medicine record

Use as a visualization aid in the cystoscopic assessment of the integrity of the ureters

Use listed on the medicine record

Human immunodeficiency virus type 1 (HIV-1) infection

Use listed on the medicine record

Isoniazid tablets, USP are recommended for all forms of tuberculosis in which organisms are susceptible. However, active tuberculosis must be treated with multiple concomitant anti-tuberculosis medications to prevent the emergence of drug resistance. Single-drug treatment of active tuberculosis with isoniazid or any other medication, is inadequate therapy. Isoniazid tablets, USP are recommended as preventive therapy for the following groups, regardless of age.

Use listed on the medicine record

The acute treatment of migraine with or without aura

Use listed on the medicine record

Community-acquired bacterial pneumonia (CABP) caused by susceptible microorganisms

Use listed on the medicine record

Pre‑exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1

Use listed on the medicine record

Neurological manifestations of Niemann-Pick disease type C

Use listed on the medicine record

Pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate

Use listed on the medicine record

HIV-1 infection

Use listed on the medicine record

Cystic fibrosis

Use listed on the medicine record

Malaria

Use listed on the medicine record

Metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy

Use listed on the medicine record

Thrombocytopenia